Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer disease
- 6 Downloads
Lipid peroxidation has been suggested to be a potential cause of neuronal damage in neurodegenerative diseases. Changes in several parameters of lipid peroxidation, including basal (unstimulated) lipid peroxidation, stimulated lipid peroxidation, tissue iron concentrations, and the concentrations of some oxygen radical scavengers, have been reported in neurodegenerative diseases. However, the in vitro interaction of oxygen radical scavengers and stimulated lipid peroxidation in neurodegenerative disease has been less wellstudied. The purpose of the present study was to determine the effects of oxygen radical scavengers on ascorbate-stimulated lipid peroxidation in Alzheimer disease (AD). We have found that some parameters of ascorbate-stimulated lipid peroxidation are altered in AD and that the effects of superoxide dismutase (SOD) on ascorbatestimulated lipid peroxidation are significantly different in AD as compared to aged.
Index EntriesAlzheimer disease lipid peroxidation iron brain antioxidants aging
Unable to display preview. Download preview PDF.
- Andorn A. C., Bacon B. R., Nguyen-Hunh A. T., Parlato S. J., and Stitts J. A. (1988) Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.Mol. Pharmacol. 33, 155–162.PubMedGoogle Scholar
- Gsell W., Conrad R., Hickethier M., Sofic E., Frölich L., Wichart I., Jellinger K., Moll G., Ransmayr G., Beckmann H., and Riederer P. (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.J. Neurochem. 64, 1216–1223.PubMedCrossRefGoogle Scholar
- Hirano A. and Zimmerman H. M. (1962) Alzheimer’s neurofibrillary changes—a topographic study.Arch. Neurol. 7, 73–88.Google Scholar
- Kohn H. I. and Liversedge M. (1944) On a new aerobic metabolite whose production by brain is inhibited by apomorphine, emetine, ergotamine, epinephrine and menadione.J. Pharmacol. Exp. Ther. 82, 292–300.Google Scholar
- Torrance J. D. and Bothwell T. H. (1980) Tissue iron stores, inIron (Cook J. D., ed.), Churchill-Livingstone, New York, pp. 90–115.Google Scholar